
Erloday 150mg Tablet
Manufacturer
Axiommax Oncology Pvt Ltd
Salt Composition
Erlotinib (150mg)
Key Information
Short Description
Erloday 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Dosage Form
Tablet
Introduction
Erloday 150mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erloday 150mg Tablet is to be taken empty stomach.
How it works
Erloday 150mg Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger EGFR, hence inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.
Quick Tips
Erloday 150mg Tablet helps treat non-small cell lung cancer that is locally advanced or has spread to other areas of the body. It should be taken 1 hour before or 2 hours after the meal. It makes your skin sensitive towards sunlight. Apply sunscreen or wear protective clothing while going out. It is advisable to avoid smoking while taking this medicine as it makes the drug ineffective and requires dose adjustment. It is not recommended during pregnancy or while breastfeeding.
Related Medicines

Erlocip 150 Tablet

Erlot 150mg Tablet

Erlomy 150mg Tablet

Etbmed 150mg Tablet

Erlotad 150 Tablet

Erlib 150mg Tablet

Bderlo 150mg Tablet

Erlosam 150mg Tablet

Birlotib 150 Tablet
